Assessment of serum inflammatory parameters in RRMS and SPMS patients

DISCUSSION: Significant differences were found in BAFF, gp130, MMP-2 and osteopontin levels between RRMS and SPMS patients. Serum IL-32 levels were statistically lower in RRMS patients treated with disease-modifying therapy than in treatment-naïve patients.PMID:38697017 | DOI:10.1080/01616412.2024.2337503

Source: Neurological Research - May 2, 2024 Category: Neurology Authors: Maria Nowak-Kiczmer Natalia Niedziela Zenon P Czuba Pawe ł Sowa Krzysztof Wierzbicki Micha ł Lubczyński Monika Adamczyk-Sowa Source Type: research